We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSET icon
1276
Bassett Furniture
BSET
$170M
$276K ﹤0.01%
16,834
-9,313
-36% -$177K
KMDA icon
1277
Kamada
KMDA
$403M
$276K ﹤0.01%
+48,320
New +$272K
BFC icon
1278
Bank First Corp
BFC
$1.64B
$272K ﹤0.01%
+4,584
New +$245K
SENS icon
1279
Senseonics Holdings Inc
SENS
$263M
$272K ﹤0.01%
+5,560
New +$296K
SIOX
1280
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$272K ﹤0.01%
+25,609
New +$255K
AC
1281
DELISTED
Associated Capital Group
AC
$270K ﹤0.01%
+6,869
New +$281K
PSEC icon
1282
Prospect Capital
PSEC
$1.13B
$269K ﹤0.01%
+41,321
New +$275K
FRST icon
1283
Primis Financial Corp
FRST
$388M
$265K ﹤0.01%
18,088
+13,176
+268% +$199K
CVGI icon
1284
Commercial Vehicle Group
CVGI
$152M
$264K ﹤0.01%
34,399
-16,439
-32% -$123K
NTRA icon
1285
Natera
NTRA
$37.1B
$264K ﹤0.01%
+12,790
New +$200K
PBYI icon
1286
Puma Biotechnology
PBYI
$413M
$263K ﹤0.01%
6,788
-5,008
-42% -$153K
GBL
1287
DELISTED
GAMCO Investors, Inc.
GBL
$263K ﹤0.01%
12,811
+5,901
+85% +$117K
CVIA
1288
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$261K ﹤0.01%
+46,778
New +$241K
BOCH
1289
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$260K ﹤0.01%
24,639
+20,102
+443% +$222K
AQ
1290
DELISTED
Aquantia Corp. Common Stock
AQ
$260K ﹤0.01%
+28,653
New +$245K
AINC
1291
DELISTED
Ashford Inc.
AINC
$259K ﹤0.01%
4,656
-14,104
-75% -$811K
EXLS icon
1292
EXL Service
EXLS
$4.41B
$258K ﹤0.01%
21,525
-88,945
-81% -$1.04M
KOD icon
1293
Kodiak Sciences
KOD
$2.66B
$258K ﹤0.01%
+39,591
New +$293K
ENR icon
1294
Energizer
ENR
$1.44B
$252K ﹤0.01%
+5,609
New +$259K
MRLN
1295
DELISTED
Marlin Business Services Corp
MRLN
$250K ﹤0.01%
+11,620
New +$267K
MNTV
1296
DELISTED
Momentive Global Inc. Common Stock
MNTV
$248K ﹤0.01%
+13,606
New +$191K
KEY icon
1297
KeyCorp
KEY
$24.1B
$246K ﹤0.01%
15,615
-425,761
-96% -$7.1M
MDRX
1298
DELISTED
Veradigm Inc. Common Stock
MDRX
$246K ﹤0.01%
25,795
-246,085
-91% -$2.72M
XERS icon
1299
Xeris Biopharma Holdings
XERS
$1.46B
$245K ﹤0.01%
+24,451
New +$313K
OLBK
1300
DELISTED
Old Line Bancshares, Inc.
OLBK
$245K ﹤0.01%
+9,845
New +$270K

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.